Trials / Terminated
TerminatedNCT02345421
A Study to Identify and Characterize LAL-D Patients in High-risk Populations
A Study to Identify the Frequency of Lysosomal Acid Lipase Deficiency in At-Risk Patient Populations
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 640 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the frequency of Lysosomal Acid Lipase Deficiency (LAL D) by lysosomal acid lipase (LAL) enzyme activity assay in patients who are considered to be at risk.
Conditions
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-09-01
- Completion
- 2015-10-01
- First posted
- 2015-01-26
- Last updated
- 2016-05-24
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02345421. Inclusion in this directory is not an endorsement.